FdaApplication
ANDA 219755
Identifiers
- fda_app_no: ANDA219755
Properties
| Property | Value |
|---|---|
| applicant_name | INVENTIA HEALTHCARE LIMITED |
| application_type | ANDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 5MG | TABLET, EXTENDED RELEASE |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 500MG | TABLET, EXTENDED RELEASE |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 2.5MG | TABLET, EXTENDED RELEASE |
4 products